🎥🗓️ Explore our recap of expert interviews and insights from the past month, including disease state pearls, insights into risks associated with treatment, spotlights on advanced practice providers and APP organizations, and more. https://lnkd.in/gxY6PDiJ
Dermatology Times’ Post
More Relevant Posts
-
Findings highlight the Patient-Reported Outcomes Measurement Information System domains most likely to be relevant to patients with chronic skin disease as well as gaps in domain coverage, such as appearance and body image. https://ja.ma/4aD5zwi
-
Drug hunter - bringing new therapeutic ideas and medicine for immunological disorders
How to improve clinical response rate? One way is to understand and define/stratify patients by disease module and signature to match with available treatment to increase probability of response. https://lnkd.in/eTheUU3E
-
Get informed with our Q&A on the diagnosis, treatment and monitoring of AL amyloidosis. This resource answers important questions about the disease, from early symptoms to the latest treatment options and monitoring strategies. Read the full Q&A here: https://lnkd.in/d482jdny #ALamyloidosis
-
📚 STUDY FINDINGS: Deucravacitinib significantly improved symptoms, signs, and quality of life in Japanese patients with plaque, generalized pustular, and erythrodermic psoriasis, with over two-thirds achieving minimal disease impact by week 52. 🔗 Read more: https://lnkd.in/e97BBY4j
-
Explore the latest innovations and clinical trial challenges in retinal disease treatment with expert insights from Arshad M. Khanani. Watch the full video here: https://lnkd.in/guRvpuEq?
-
Oligometastatic disease does not preclude effective pelvic exenteration 🪡 read our summary 👉 https://lnkd.in/dec2iiby by Vu JK, Brown KGM (...) Steffens D et 8 al. in Dis Colon Rectum
-
Upon completion of this activity, you should be better prepared to explain the evidence supporting the current understanding of #hidradenitissuppurativa, assess disease severity using recommended instruments and evaluations, and more. https://lnkd.in/gh6dTf-8
-
🌍❤️ Today marks the beginning of International Heart Valve Disease Awareness Week — a time to shine a light on the importance of early diagnosis and intervention for heart valve conditions. At Eko, we’re committed to advancing early detection technologies to improve patient outcomes. This week, we encourage you to refresh your knowledge on tricuspid regurgitation, one of the most common and often undiagnosed heart valve diseases. By raising awareness, we can ensure more patients receive timely care and treatment. ➡️ Learn more: https://bit.ly/3XEUbfl #HeartHealth #HeartValveDisease #EarlyDiagnosis #AwarenessMatters
-
Understanding the nuances of IgG4-RD can be key to improving patient outcomes. In this educational program, Drs. John Stone, Bart Chwalisz, and Marcela Marsiglia explore the identification and management of IgG4-related disease, particularly when it involves the skull base. This case-based discussion focuses on the importance of prompt diagnosis and intervention for this condition and highlights strategies for excluding key mimickers and preventing unnecessary interventions. Enhance your practice with expert insights: https://ow.ly/YYZY50T4nFg #CME #MedEd #IgG4RD
